Key result
Healthcare delays in STEMI linked to ~25% higher 1-year major cardiovascular events risk.
Why the study?
STEMI is common in young patients and treatment delays worsen prognosis, but ischaemia-reperfusion times and their long-term outcomes in very young patients compared to older individuals needed evaluation.
Does age ≤40 years improve ischaemia-reperfusion times and reduce MACE in patients with STEMI compared to age >40 years?
Cohort (n=6,799)
Yes
Does age ≤40 years improve ischaemia-reperfusion times and reduce MACE in patients with STEMI compared to age >40 years?
Young patients (≤40 years) with STEMI experience shorter ischaemia-reperfusion times, while healthcare delays are associated with a higher risk of MACE at 1 year.
Answers are grounded in this paper and cite their sources.
Healthcare delay was associated with higher MACE; leaves open whether age-specific strategies reduce events in young STEMI patients.
INTRODUCTION: ST-elevation myocardial infarction (STEMI) is one of the most prevalent presentations in young patients. It is essential to emphasise that each minute of delay in providing medical care is negatively correlated to the patient's prognosis. The present study was carried out to evaluate the ischaemia-reperfusion times in patients ≤40 years of age versus individuals >40 years of age and their association with mortality and major adverse cardiac event (MACE) over the long term. METHODS: A retrospective, multicentre cohort study was carried out in 6799 patients diagnosed with STEMI. Two groups were established: patients diagnosed with STEMI and aged >40 years, and patients diagnosed with STEMI and aged ≤40 years. RESULTS: The patients in the young group had a significantly sooner electrocardiographic diagnosis than the patients >40 years of age. A delay was observed in females, with a relative risk (RR) of 1.21 (95% CI 1.13 to 1.30) (p<0.001). Presenting dyspnoea (RR 1.76, 95% CI 1.5 to 2.06) (p<0.001) or going to a hospital without haemodynamics (RR 1.55, 95% CI 1.45 to 1.67) (p<0.001) was related to increased delay. The occurrence of MACE in the first year of follow-up was related to different risk factors, along with a delay in healthcare (HR 1.25, 95% CI 1.10 to 1.54) (p<0.042). CONCLUSION: This study shows that young patients with STEMI tend to receive a sooner diagnosis than older individuals. Delays in healthcare represent one of the main factors related to the occurrence of MACE and non-event-free survival.
No takes yet. Share an insight, caveat, or question.
Juan‐Salvadores et al. (2025) conducted a cohort in ST-elevation myocardial infarction (STEMI) (n=6,799). Delay in healthcare vs. Timely healthcare was evaluated on Major adverse cardiac event (MACE) in the first year of follow-up (HR 1.25, 95% CI 1.10 to 1.54, p=<0.042). Delays in healthcare for patients with STEMI were associated with an increased risk of major adverse cardiac events in the first year of follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: